Latest Industry Insights

To find out more about the Taiwan Precision Medicine Initiative and its aim to implement a sustainable precision health ecosystem in Taiwan, we spoke to Dr. Pui-Yan Kwok, leader of the initiative.

We spoke to Darlene Solomon to learn more about improving sustainability in science and Agilent’s commitment to My Green Lab and other sustainability initiatives.

In this interview, we speak to Vikram Devgan at NanoString Technologies to learn more about how added context from spatial biology techniques can provide more detailed insights during tissue analysis.

In this interview, Sebastian Selzer discusses the advantages of cell culture in stirred-tank bioreactors.

This article discusses the importance of data lineage and traceability for academic labs looking to maximize their publishing potential.

This article walks through the fundamentals of CRISPR screening and its most exciting applications, including unpicking cellular signaling networks, discovering how viruses like COVID-19 infect our cells and finding new drug targets.

This article discusses an innovative biofabrication method that uses a single 3D hydrodynamic flow focusing chip to generate different hydrogel configurations with specific geometries for various biological applications.

Technology Networks recently had the pleasure of speaking with Mark Fidock, vice president for Diagnostic Development, Precision Medicine at AstraZeneca, to find out how the company is “rising to the challenge” of delivering precision medicines for chronic diseases.

Technology Networks recently spoke to Drew Buskirk to learn more about peak variation and why it is so important to measure.

The biotech/genetic engineering company Colossal – co-founded in 2021 by renowned geneticist Professor George Church and serial entrepreneur Ben Lamm – announced it has begun a de-extinction project of the thylacine – an Australian marsupial commonly referred to as the “Tasmanian tiger”. Technology Networks interviewed the team to learn more.